Hodgkin\'s Lymphoma News
Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (September 24, 2009)Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the results of a study published in Blood.[1] Although children and adolescents with Hodgkin’s lymphoma have an excellent... Continue Reading
Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)Hodgkin’s Survivors at Increased Risk of Stroke Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute. Hodgkin’s... Continue Reading
Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers (June 23, 2009)Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers Industrial workers who are exposed to formaldehyde may be at an increased risk of dying from blood and lymphatic cancers, particularly myeloid leukemia but also Hodgkin’s lymphoma... Continue Reading
Gemzar®/Navelbine® Effective and Well-tolerated in Children with Relapsed/Refractory Hodgkin’s Disease (May 7, 2009)The combination of Gemzar® (gemcitabine) and Navelbine® (vinorelbine) appears to be effective and well-tolerated for reinduction in children with relapsed or refractory Hodgkin’s disease, according to the results of a study published in the Journal... Continue Reading
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma (March 8, 2009)Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics... Continue Reading
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors (March 8, 2009)Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors According to the results of a study published in the Annals of Oncology, annual screening mammography may miss some cases of early invasive breast cancer among young Hodgkin’s... Continue Reading
Lymphoma Patients: Understanding Peripheral Neuropathy (February 6, 2009)If you’ve received chemotherapy as part of your lymphoma treatment, one of the side effects you may experience is numbness and tingling in you extremities, also known as peripheral neuropathy. The following guidelines explain how to recognize and manage... Continue Reading
It’s Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma (February 6, 2009)Many cancer patients are at an increased risk of infection because of their low levels of infection-fighting white blood cells, a condition called neutropenia. The most common reason that cancer patients experience neutropenia is as a side effect of chemotherapy.... Continue Reading
Successful Treatment for Lymphoma Means Staying on Schedule (February 6, 2009)In order to receive the best possible benefit from your lymphoma therapy, it is important to follow your treatment as your doctor has prescribed. Even if you’re not able to visit your regular treatment facility, chances are good that you can still... Continue Reading
Understanding Stem Cell Transplants (February 6, 2009)High-dose chemotherapy and bone marrow or blood stem cell transplantation (SCT) remains the best treatment available for selected patients with certain types of leukemia. The SCT process was developed more than 36 years ago and was considered such a major... Continue Reading